Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07312396Not yet recruiting
Randomised, open-label trial in gouty arthritis (2 arms). Primary endpoint: Frequency of gout attacks at 24 weeks. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07312396.